Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-25-000387
Filing Date
2025-11-25
Accepted
2025-11-25 16:21:31
Documents
1
Period of Report
2025-11-21

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3208
  Complete submission text file 0001610717-25-000387.txt   4675
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Issuer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210 WALTHAM MA 02451
Business Address
Reilly Joseph James (Reporting) CIK: 0002044416 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36485 | Film No.: 251521566